Kevlicius L, Cepulyte R, Vasilevska D, Griskevicius L, et al. Venetoclax-based regimens in combination with trametinib for RAS-mutated relapsed or refractory myeloid malignancies. Bone Marrow Transplant 2022;57:1034-1037.
PMID: 35430592